Science

A recent scientific review of yeast-derived beta-glucans highlights a number of promising insights into the activity of beta-glucans on the immune system.

A recent animal study found that administration of pyrroloquinoline quinone (PQQ) from Nascent Health Sciences reduced the risk of chronic heart failure.

A recent study found that supplementation with tocotrienol-rich vitamin E (EVNol SupraBio from ExcelVite) supported nerve growth factor and nerve conduction velocities in the nerves of diabetic peripheral neuropathy patients.

A recently published study looked at the effects of a branded curcumin extract on serum cytokine concentration in critically-ill patients.

In its report to House and Senate Committees on Appropriations, FDA broke down the results of several years of sample studies the agency conducted on CBD products from 2014 to 2020.

The newly published findings show that resveratrol supplementation supports bone mineral density in postmenopausal women.

Postbiotics are still at the beginning of their market journey while promising a multitude of health benefits.

A new market report published by Leafreport, in partnership with Las Vegas’ Canalysis Laboratories, measured the accuracy of CBD-content claims on a sample of 37 hemp-derived CBD products.

Echinacea and elderberry have been dominant in the immune health category; however, a number of other herbs used as natural remedies since ancient times have shown promising results in clinical trials.

Artemis International is strengthening its partnership with the American Botanical Council’s Botanical Adulterants Prevention Program and botanical testing specialist Alkemist Labs to investigate suspicions that adulterated elderberry ingredients are infiltrating the U.S. market.

In a recently published study, a tomato-based oral supplement containing lycopene was found to support signs of aging on skin.

A new study published in PLOS ONE found colostrum products on the market deliver widely different bioactivity based on several quality factors.

Thymoquinone, the main bioactive quinone in black seed oil is known to be an antioxidant, and supports inflammation, while omega-3s have been known to support insulin sensitivity and glucose homeostasis in obesity.

HempFusion will be one of ten companies to sponsor and participate in a new human clinical trial conducted by ValidCare to determine if daily use of full-spectrum hemp-derived CBD or CBD isolate impacts the human liver.

Results showed that compared to placebo supplementation significantly prevented UV irradiation induced skin pigmentation.

The adaptogen market is growing thanks to clinical research substantiating its traditional medicine halo.

The adaptogen market is growing thanks to clinical research substantiating its traditional medicine halo.

OmniActive Health Technologies presented three posters at Nutrition 2020 Live Online on dry eye disease and osteoarthrosis.

The first published research from the PREDICT (Personalized Responses to Dietary Composition Trial) studies found that post-prandial responses following identical meals vary widely between individuals. 

ChromaDex Corp. (Los Angeles, CA) earned ISO/IEC 17025:2017 accreditation for testing of the its Tru Niagen consumer products, Niagen ingredient, and phytochemical reference standards performed out of its Longmont, CO quality control and R&D facility. 

Sabinsa Corp. is calling attention to the practice of mischaracterizing the herb amla (Emblica officinalis) to be a valuable source of vitamin C.

Will the COVID-19 pandemic have an impact on food safety?

Alkemist Labs’ ISO/IEC 17025:2017 accreditation from the American Association for Laboratory Accreditation (A2LA) has been renewed until Feb. 28, 2022.

Danone North America partnered with the bioscience company Brightseed, creator of an artificial intelligence (AI) technology that maps novel plant nutrients to human health, to investigate plant sources for unknown health and nutrition benefits.

The American Gastroenterological Association released new clinical guidelines which find that there is not enough evidence to support the use of probiotics for most digestive conditions. However, the guidelines do conditionally support the use of certain probiotic formulations in three specific clinical settings.